Evidence map›Paper›PMID 40874343›Full record

ArticleHaematologica2026

CXCR2 deficiency with myelokathexis caused by a novel variant: correction via CRISPR/Cas9.

Daniëla M Hinke, Sofie R Dorset, Eirik Bratland, Jonas H Wolff, Astrid M Olsnes, Jacob Giehm Mikkelsen, Lars Helgeland, Rasmus O Bak, Andreas Benneche, Trine H Mogensen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daniëla M HinkeDepartment of Biomedicine, Aarhus University, Aarhus, Denmark; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Center for Immunology of Viral infections (CIVIA), Aarhus University, Aarhus.
Sofie R DorsetDepartment of Biomedicine, Aarhus University, Aarhus.
Eirik BratlandDepartment of Medical Genetics, Haukeland University Hospital, Bergen.
Jonas H WolffDepartment of Biomedicine, Aarhus University, Aarhus, Denmark; Center for Immunology of Viral infections (CIVIA), Aarhus University, Aarhus.
Astrid M OlsnesDepartment of Clinical Science, University of Bergen, Norway; Department of Hematology, Department of medicine, Haukeland University Hospital, Bergen.
Jacob Giehm MikkelsenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark; Center for Immunology of Viral infections (CIVIA), Aarhus University, Aarhus.
Lars HelgelandDepartment of Pathology, Haukeland University Hospital, Bergen.
Rasmus O BakDepartment of Biomedicine, Aarhus University, Aarhus.
Andreas BennecheDepartment of Medical Genetics, Haukeland University Hospital, Bergen.
Trine H MogensenDepartment of Biomedicine, Aarhus University, Aarhus, Denmark; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark; Center for Immunology of Viral infections (CIVIA), Aarhus University, Aarhus. Trine.mogensen@biomed.au.dk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40874343
PMCPMC12862296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.